Delivery Order SPE2DE24D0013-SPE2D625F0EFL

The Defense Logistics Agency's Medical Supply Chain division awarded an $6.8K firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer specializing in infectious disease testing solutions. This delivery order, issued on August 5, 2025, with an ultimate completion date of August 12, 2025, is designated as XPCOV2/FLU/RSV-10 and relates to diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV). The contract carries no set-aside designation and represents a continuation of Cepheid's established relationship with federal healthcare procurement, leveraging the company's GeneXpert diagnostic platform and associated reagent supply capabilities.

This delivery order likely derives from one of Cepheid's existing Indefinite Delivery Vehicle contracts, most notably its $32.8M single-award IDV with the VA's Veterans Integrated Service Network 6, which runs through September 30, 2030, and provides molecular diagnostic testing system reagents and assays. Cepheid's federal portfolio demonstrates consistent demand for its PCR-based diagnostic solutions across the VA healthcare system and Defense Health Agency networks, with previous contract values ranging from thousands to nearly $1M. The relatively modest ceiling value of this particular delivery order suggests a targeted procurement to support immediate diagnostic testing needs within the defense healthcare supply chain.